Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Diabetes Metab Syndr ; 7(1): 38-41, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23517795

RESUMEN

AIMS: To examine the protein oxidation, marker of the oxidative stress, in metabolic syndrome (MS). METHODS: We enrolled 106 subjects (45 women and 61 men) with MS of which 43 (14 women and 27 men) were with diabetes mellitus and 63 (31 women and 32 men) were without diabetes mellitus, and 54 subjects (19 women and 35 men) as control group. The protein oxidation, expressed as carbonyl groups, was measured by an enzyme-like immunosorbent assay (ELISA) kit (BioCell PC test kit, Enzo Life Sciences AG, Switzerland). RESULTS: In the whole group of MS subjects, in comparison with control group, a significant increase in carbonyl groups was present. The same datum was also evident between control group and diabetic subjects with MS and between control group and nondiabetic subjects with MS. No difference was observed between the two subgroups (diabetic and nondiabetic subjects with MS) about NOx. Few information were obtained examining the linear regression among carbonyl groups, age, BMI, waist circumference, blood pressure values and metabolic pattern of MS subjects. CONCLUSIONS: In MS subject we observed an increase of protein oxidation not influenced by diabetes mellitus. Several strategies may be employed to reduce this parameter.


Asunto(s)
Glucemia/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Síndrome Metabólico/metabolismo , Óxido Nítrico/metabolismo , Carbonilación Proteica , Biomarcadores/metabolismo , Presión Sanguínea , Diabetes Mellitus Tipo 2/epidemiología , Diabetes Mellitus Tipo 2/fisiopatología , Femenino , Humanos , India/epidemiología , Inflamación/metabolismo , Masculino , Síndrome Metabólico/epidemiología , Síndrome Metabólico/fisiopatología , Persona de Mediana Edad , Oxidación-Reducción , Estrés Oxidativo , Circunferencia de la Cintura
2.
Clin J Sport Med ; 19(4): 306-10, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19638825

RESUMEN

OBJECTIVE: To evaluate erythrocyte deformability, nitric oxide metabolites, and their modifications induced by exercise in athletes who practised different sports. DESIGN: This evaluation was effected before and after cardiopulmonary test, using a cycloergometer. SETTING: The study was performed in the Department of Internal Medicine, Cardiovascular and Renal Diseases of the University of Palermo. PARTICIPANTS: We enrolled 62 male athletes who practised endurance (n = 23), mixed (n = 20), and power (n = 19) sports and 20 sedentary male subjects as controls. ASSESSMENT OF RISK FACTORS: No subject had diabetes or hypertension or dyslipidemia. Five control subjects and 14 athletes were smokers. MAIN OUTCOME MEASURES: Erythrocyte deformability was examined as elongation index (EI) using a diffractometer. The nitric oxide metabolites (nitrite + nitrate = NOx) were evaluated employing the Griess reagent. RESULTS: In the whole group, an increase in EI and NOx was present. Subdividing the whole group into 3 subgroups, we noted an increase in EI and NOx only in endurance and mixed athletes. The EI before and after the cardiopulmonary test significantly decreased in the whole group and in power athletes but not in endurance and mixed athletes. Before and after the test, NOx did not significantly change in the whole group and in the 3 subgroups. CONCLUSIONS: In athletes who practised endurance and mixed sports, we observed an increase of NOx level and an increase of erythrocyte deformability. The latter did not change after an exercise test in the same subgroups, whereas it decreased in power athletes.


Asunto(s)
Fenómenos Fisiológicos Cardiovasculares , Deformación Eritrocítica/fisiología , Ejercicio Físico/fisiología , Óxido Nítrico/metabolismo , Adulto , Humanos , Italia , Masculino , Persona de Mediana Edad , Nitratos/sangre , Nitritos/sangre , Deportes/fisiología
3.
Clin Hemorheol Microcirc ; 40(1): 31-6, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18791265

RESUMEN

In a group of young subjects with acute myocardial infarction (AMI) (68 men and 7 women; mean age 39.6+/-5.7 years) we examined the plasma concentration of elastase, the thiobarbituric acid-reactive substances (TBARS) and the total antioxidant status (TAS) at the initial stage of AMI. In this group we found an increase of elastase (p<0.001) and TBARS (p<0.001) and a decrease of TAS (p<0.001). A statistical correlation was observed in the whole group of AMI patients between plasma elastase and TAS (p<0.01) and this correlation was more statistically significant in patients with more risk factors and not in those with more involved vessels.


Asunto(s)
Antioxidantes/metabolismo , Infarto del Miocardio/sangre , Estrés Oxidativo/fisiología , Elastasa Pancreática/sangre , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Adulto , Biomarcadores/sangre , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/enzimología
4.
Clin Hemorheol Microcirc ; 35(1-2): 199-201, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16899927

RESUMEN

An abnormal activation state of polymorphonuclear leukocytes (PMN) plays a key role in organ injury induced by vascular atherosclerotic disease (VAD) and diabetes mellitus (DM). PMN membrane fluidity and cytosolic Ca2+ content can be considered markers of PMN activation. In this research we evaluated the PMN membrane fluidity and cytosolic Ca2+ content in VAD subjects with and without type 2 DM and examined the association between these parameters and the mono- or polyvascular localization. We enrolled 155 VAD subjects, including 92 non-diabetic (group A: mean age 63.6 +/- 9.2 years) and 63 diabetic patients (group B: mean age 65.4 +/- 7.8 years). Among group A 63 patients had monovascular and 29 polyvascular disease; among group B 30 patients had monovascular and 22 polyvascular disease. In each patient we evaluated the PMN membrane fluidity labelling the cells with the fluorescent probe 1,4-(trimethylamino)-phenyl-4-phenylhexatriene (TMA-DPH) and the PMN cytosolic Ca2+ content marking the cells with the fluorescent probe Fura 2-AM. PMN membrane fluidity did not discriminate normal subjects from diabetic and non-diabetic VAD subjects, while cytosolic Ca2+ content was increased in both groups. PMN membrane fluidity did not distinguish normal subjects from mono- or polyvascular VAD patients with and without type 2 DM. PMN cytosolic Ca2+ content was increased especially in monovascular VAD patients; both mono- and polyvascular VAD subjects with DM had a PMN cytosolic Ca2+ content higher than normals. Our results show the presence of an increased PMN cytosolic Ca2+ content in diabetic and non-diabetic VAD subjects but no association was observed between this increase and the mono- or polyvascular localization.


Asunto(s)
Aterosclerosis/sangre , Calcio/análisis , Membrana Celular/fisiología , Fluidez de la Membrana , Neutrófilos/fisiología , Anciano , Aterosclerosis/patología , Diabetes Mellitus Tipo 2/sangre , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neutrófilos/química , Índice de Severidad de la Enfermedad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA